A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2011
10/06/2011	WO2011121105A1 Macrocyclic integrase inhibitors
10/06/2011	WO2011121096A1 PYRAZOL[1,5-a]PYRIMIDINE DERIVATIVES AS WNT PATHWAY ANTAGONISTS
10/06/2011	WO2011121082A1 Bioadhesive compositions of local anaesthetics
10/06/2011	WO2011121068A1 Amino derivatives of cyclohex-2-enone, their preparation and use as antioxidants
10/06/2011	WO2011121055A1 Pyridinyl derivatives comprising a cyanoguanidine or squaric acid moiety
10/06/2011	WO2011120953A1 Polymers for delivering molecules of interest
10/06/2011	WO2011120930A1 Method for stimulating the reproductive capacity in a bull, and composition for stimulating the reproductive capacity in a bull
10/06/2011	WO2011120925A1 Parenteral pharmaceutical form which releases aromatse inhibitor and gestagens, for the treatment of endometriosis
10/06/2011	WO2011120923A1 Pharmaceutical composition comprising an sglt2 inhibitor and a ppar- gamma agonist and uses thereof
10/06/2011	WO2011120922A1 Use of novel pan-cdk inhibitors for treating tumors
10/06/2011	WO2011120911A1 Pkc inhibitors for the treatment of b-cell lymphoma having chronic active b-cell-receptor signalling
10/06/2011	WO2011120902A1 Protein tyrosine phosphatase, non-receptor type 11 (ptpn11) and tumor initiating cells
10/06/2011	WO2011120886A1 A process for the preparation of (-)-englerin a, and analogues and intermediates thereof
10/06/2011	WO2011120877A1 Aryl-cyclohexyl-tetraazabenzo[e]azulenes
10/06/2011	WO2011120870A1 Egfr inhibitor and antiviral agent for simultaneous, separate or sequential use in the treatment and/or prevention and/or palliation of cancer
10/06/2011	WO2011120766A1 Edible tomato-based product comprising orally bioavailable endogenous micronutrients
10/06/2011	WO2011120707A1 Compositions for dental treatment comprising lipoteichoic acids or parts thereof like mono- or polyglycerphosphates
10/06/2011	WO2011120704A1 Transdermal patch containing 17-deacetyl norgestimate
10/06/2011	WO2011120604A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
10/06/2011	WO2011120576A1 Antidiabetic enolic glucoside of phenylpyruvic acid
10/06/2011	WO2011120535A1 New biomaterial from wharton's jelly umbilical cord
10/06/2011	WO2011120474A1 Method for inhibiting hiv replication in mammal and human cells
10/06/2011	WO2011120339A1 Microemulsion formulation containing arctigenin
10/06/2011	WO2011120327A1 Anti-tumor medicament of structure of diarylurea or thiourea kind based on indazole or aza-indazole
10/06/2011	WO2011120314A1 Biphenyl compounds with antitumor activity and their preparation method
10/06/2011	WO2011120313A1 Biphenyl compounds with antitumor activity and their preparation method
10/06/2011	WO2011120303A1 Gambogic acid derivatives, preparative methods and uses thereof
10/06/2011	WO2011120281A1 Use of l-oxiracetam in manufacture of medicaments for preventing or treating cognitive dysfunction
10/06/2011	WO2011120182A2 Use of at least one dialkyl thiosulfonate or thiosulfinate for reducing the number of apicomplexa in an animal
10/06/2011	WO2011120156A1 Polyamine-containing polymers and methods of synthesis and use
10/06/2011	WO2011120153A1 Compounds and method for treatment of hiv
10/06/2011	WO2011120133A1 Non-nucleoside reverse transcriptase inhibitors
10/06/2011	WO2011120084A1 Transdermal delivery patch
10/06/2011	WO2011120082A1 A method of modulating protein 14-3-3 functionality by facilitating or inhibiting phosphorylation
10/06/2011	WO2011120070A1 Transdermal delivery patch
10/06/2011	WO2011098262A3 P19arf, hmga2 and mdm2 for use in the diagnosis and treatment of aberrant cell growth
10/06/2011	WO2011089234A3 Aqueous solution comprising 3 - quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease
10/06/2011	WO2011085216A3 Use of faah inhibitors for treating parkinson's disease and restless legs syndrome
10/06/2011	WO2011081280A3 Novel glucokinase activators and processes for the preparation thereof
10/06/2011	WO2011077452A3 Fast dissolving pharmaceutical composition comprising lornoxicam
10/06/2011	WO2011072138A9 Therapeutic use of protein-polymer conjugates
10/06/2011	WO2011071849A3 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
10/06/2011	WO2011069141A3 Interferon therapies in combination with blockade of stat3 activation
10/06/2011	WO2011066260A3 Formulations comprising aminosterols
10/06/2011	WO2011063164A3 Sustained release cannabinoid medicaments
10/06/2011	WO2011062906A9 Treatment of atrial fibriallation
10/06/2011	WO2011062765A3 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
10/06/2011	WO2011061519A3 Topical foam composition
10/06/2011	WO2011060268A3 Diagnosis and treatment of cancer using histone deacetylase inhibitors and radiolabeled metaiodobenzylguanidine
10/06/2011	WO2011059763A3 Dimeric smac mimetics
10/06/2011	WO2011058508A3 Compositions for the treatment of chemoresistant leukaemia and/or of potentially chemoresistant leukaemia
10/06/2011	WO2011053917A3 Gastroretentive oral high dose zinc preparations
10/06/2011	WO2011053660A3 Novel therapeutic rna interference technology targeted to the pdx-1 oncogene in pdx-1 expressing neuroendocrine tumors
10/06/2011	WO2011050357A3 Protein arginine deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer
10/06/2011	WO2011046382A3 Nrf2 inhibitors and use thereof
10/06/2011	WO2011046303A3 Novel method for preparing entecavir and intermediate used therein
10/06/2011	WO2011044537A9 Methods for treating alzheimer's disease
10/06/2011	WO2011041451A3 Smoking cessation with body weight maintenance and nutritional supplement
10/06/2011	WO2011035143A4 Methods and compositions for inhibiting rho-mediated diseases and conditions
10/06/2011	WO2011035110A3 Treatment for oxidative stress and/or hypertension
10/06/2011	WO2011034583A3 Inhibition of endosomal toll-like receptor activation
10/06/2011	WO2011019956A3 Pharmaceutical compositions with tetrabenazine
10/06/2011	WO2011019815A3 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
10/06/2011	WO2011016057A3 Controlled release pharmaceutical compositions of milnacipran
10/06/2011	WO2010131035A8 Novel crystalline polymorph of sitagliptin dihydrogen phosphate
10/06/2011	WO2010114824A8 Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
10/06/2011	WO2010104406A8 Prodrug forms of kinase inhibitors and their use in therapy
10/06/2011	WO2010103279A8 Bis aromatic compounds for use as ltc4 synthase inhibitors
10/06/2011	WO2010074588A8 Pharmaceutical compounds
10/06/2011	WO2010047956A9 Azolopyrrolone melanin concentrating hormone receptor-1 antagonists
10/06/2011	US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins
10/06/2011	US20110245784 Anti-infective compositions, methods and systems for treating pathogen-induced disordered tissues
10/06/2011	US20110245772 Focal calcium channel modulation
10/06/2011	US20110245757 Method for treating chronic wounds with an extracellular polymeric substance solvating system
10/06/2011	US20110245501 Substituted Tetracycline Compounds as Synergistic Antifungal Agents
10/06/2011	US20110245349 Benzyl alcohol mixture for treating premature ejaculation
10/06/2011	US20110245348 Method of treating type I diabetes
10/06/2011	US20110245347 Method for selectively crystallizing a z isomer of iopromide
10/06/2011	US20110245346 Novel polymorphs and salts
10/06/2011	US20110245345 Topical Treatment Formulation of Natural Ingredients for Enhancing Sexual Response
10/06/2011	US20110245342 3,5,3'-triiodothyronine sulfate as thyromimetic agent and pharmaceutical formulations thereof
10/06/2011	US20110245341 Process for the preparation of non-genotoxic diacetylrhein (diacerein) and formulations comprising non-genotoxic diacetylrhein
10/06/2011	US20110245340 Screening Method for Identifying Patients at Risk of Adverse Hepatologic Events
10/06/2011	US20110245339 Prodrugs of short-chain fatty acids and treatment methods
10/06/2011	US20110245338 Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
10/06/2011	US20110245337 Method for enhancing the dna repair process, treating disorders associated with the dna repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester
10/06/2011	US20110245336 Colchicine solid complex; methods of making; and methods of use thereof
10/06/2011	US20110245335 New inhibitors for treating diseases associated with an excess transport of hyaluronan
10/06/2011	US20110245334 Use of racemates of pinocembrin in preparing medicaments for treating stroke
10/06/2011	US20110245333 Identification of free-b-ring flavonoids as potent cox-2 inhibitors
10/06/2011	US20110245332 Injectable formulations of taxanes for cad treatment
10/06/2011	US20110245331 Inhibitors of epoxide hydrolases for the treatment of hypertension
10/06/2011	US20110245330 P185neu-encoding dna and therapeutical uses thereof
10/06/2011	US20110245329 Double-stranded rna structures and constructs, and methods for generating and using the same
10/06/2011	US20110245328 HCV NS5A Replicon Shuttle Vectors
10/06/2011	US20110245327 Oligonucleotide Analogues
10/06/2011	US20110245326 Post-Transcriptional Regulation Of RNA-Related Processes Using Encoded Protein-Binding RNA Aptamers
10/06/2011	US20110245325 Pharmaceutical composition for treatment of cancer and asthma
10/06/2011	US20110245323 RIG-Like Helicase Innate Immunity Inhibits VEGF-Induced Tissue Responses
10/06/2011	US20110245322 Methods for identifying and compounds useful for increasing the functional activity and cell surface expression of cf-associated mutant cystic fibrosis transmembrane conductance regulator

1 ... 1532 1533 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 ... 7860